Gosogliptin
98%
- Product Code: 108439
CAS:
869490-23-3
| Molecular Weight: | 366.41 g./mol | Molecular Formula: | C₁₇H₂₄F₂N₆O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
Gosogliptin is primarily used in the management of type 2 diabetes mellitus. It functions as a dipeptidyl peptidase-4 (DPP-4) inhibitor, which helps regulate blood sugar levels by enhancing the body's natural ability to control glucose. By inhibiting the DPP-4 enzyme, it increases the levels of incretin hormones, such as GLP-1 and GIP, which stimulate insulin release in response to meals and reduce the production of glucagon. This dual action helps to lower blood glucose levels without causing significant hypoglycemia. Gosogliptin is often prescribed as part of a comprehensive treatment plan that includes diet and exercise. It is particularly beneficial for patients who require an oral medication with a low risk of weight gain or other adverse effects commonly associated with other antidiabetic drugs. Its once-daily dosing regimen also improves patient compliance and convenience.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | £1,063.56 |
+
-
|
Gosogliptin
Gosogliptin is primarily used in the management of type 2 diabetes mellitus. It functions as a dipeptidyl peptidase-4 (DPP-4) inhibitor, which helps regulate blood sugar levels by enhancing the body's natural ability to control glucose. By inhibiting the DPP-4 enzyme, it increases the levels of incretin hormones, such as GLP-1 and GIP, which stimulate insulin release in response to meals and reduce the production of glucagon. This dual action helps to lower blood glucose levels without causing significant hypoglycemia. Gosogliptin is often prescribed as part of a comprehensive treatment plan that includes diet and exercise. It is particularly beneficial for patients who require an oral medication with a low risk of weight gain or other adverse effects commonly associated with other antidiabetic drugs. Its once-daily dosing regimen also improves patient compliance and convenience.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :